John Lunger, Chief Patient Supply Officer: Adaptimmune Therapeutics ADAPY Planned sale · Filed 25/01/15

Trade details

Type: Planned sale notice
Stock: Adaptimmune Therapeutics ADAPY
Person: John LungerChief Patient Supply Officer
Planned sale date: 25/01/13
Filed: 25/01/15

$5,726 to be sold

Adaptimmune Therapeutics trades, last 26 weeks

What else happened in Adaptimmune Therapeutics around then

Filed or reported within 30 days of the trade day · 24/12/14~25/02/12

John Lunger's recent trades

John LungerChief Patient Supply Officer
SellAdaptimmune Therapeutics
Sell
Adaptimmune Therapeutics
ADAPY
$3,239
5,584 sh
$3,239
Filed 25/01/17
Traded 25/01/17
John LungerChief Patient Supply Officer
Planned saleAdaptimmune Therapeutics
Planned sale
Adaptimmune Therapeutics
ADAPY
$3,243
5,584 sh
$3,243
Filed 25/01/17
Traded 25/01/17
John LungerChief Patient Supply Officer
SellAdaptimmune Therapeutics
Sell
Adaptimmune Therapeutics
ADAPY
$5,588
9,803 sh
$5,588
Filed 25/01/15
Traded 25/01/15
John LungerChief Patient Supply Officer
SellAdaptimmune Therapeutics
Sell
Adaptimmune Therapeutics
ADAPY
$3,228
5,471 sh
$3,228
Filed 25/01/15
Traded 25/01/13
John LungerChief Patient Supply Officer
SellAdaptimmune Therapeutics
Sell
Adaptimmune Therapeutics
ADAPY
$2,518
4,268 sh
$2,518
Filed 25/01/15
Traded 25/01/13